Target intelligence / Profile preview

Glucosamine (GlcN)

Target
GlcN
Molecular classification
Aminosugar, Carbohydrate, Hexose monosaccharide, Polyol, Organic nitrogen compound, Organoheterocyclic compound
01

Overview

Glucosamine is a small, water-soluble amino sugar with the molecular formula C6H13NO5. It serves as a precursor in the biosynthesis of glycosaminoglycans—essential components of cartilage and connective tissue. Exogenously administered glucosamine is primarily taken for its purported chondroprotective and symptom-relieving effects in osteoarthritis, although its efficacy remains debated. Glucosamine itself is not a molecular target, but rather a substrate and building block in various biosynthetic pathways, especially those leading to the formation of proteoglycans and glycoproteins. As a supplement, common forms include glucosamine sulfate and glucosamine hydrochloride; it is typically derived from shellfish or synthetically produced.

Other names
D-glucosamine2-amino-2-deoxy-D-glucosechitosamineglucosaminaaminoglucoseglucosamine hydrochlorideglucosamine sulfateN-acetylglucosamine
02

Mechanism of action

As a supplement: hypothesized to stimulate synthesis of glycosaminoglycans and collagen in chondrocytes May inhibit degradation of cartilage by downregulating inflammatory cytokines and catabolic enzymes (proposed for glucosamine sulfate)

03

Biological functions

Precursor for the biosynthesis of glycosaminoglycans, proteoglycans, and glycoproteinsCartilage formation and maintenanceComponent of connective tissueSubstrate in the hexosamine biosynthetic pathway
04

Disease associations

Osteoarthritis (symptomatic management; not directly causal)Possible metabolic role in diabetes and insulin resistance (controversial and not well established)
05

Safety considerations

Possible influence on insulin sensitivity in diabetic patients (not well supported in humans)Potential for allergic reactions, especially in those with shellfish allergy (source-dependent)GI side effects: nausea, diarrhea, constipation
06

Biomarkers

None established for patient selection or efficacy monitoring (use is empirical in osteoarthritis)

Beyond the preview

Go deeper on Glucosamine (GlcN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucosamine (GlcN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call